SHAHAB SALEMY

Shahab Salemy is a Director of Business Development for this year’s conference.  He is a first year MBA student at the Wharton School majoring in Health Care Management.  Prior to Wharton, Shahab spent three years as Director of Corporate Strategy at McKesson Corporation.  At McKesson, he helped build the specialty pharmaceutical distribution and informatics businesses, as well as supported the turn around effort in the Medical Surgical division.  Before joining McKesson, Shahab was an Associate in the Investment Banking division of J.P. Morgan where focused both on mergers and acquisitions, and bank lending to a variety of healthcare entities.  Shahab graduated from Columbia University in 1997 with a B.A. in Economics-Political Science.

VIJAY SHREEDHAR

Vijay Shreedhar is the Director for Business Development for the WHCBC ’04. He is currently a Health Care Management M.B.A. student at the Wharton School (Class of 2005).. Trained as a scientist, Vijay worked most recently at Wyeth as a staff researcher in the vaccine division at Pearl River, NY.  He received his bachelor’s and master’s degrees in biotechnology from the University of Madras, India, and his Ph.D. in Immunology from the University of Texas, M.D. Anderson Cancer Center, Houston, TX. Vijay completed his postdoctoral studies in Immunology at Harvard Medical School and is the author of numerous scientific publications

TERENCE YAP, M.D.

Terence Yap is a Director of the Business Development team.  He is a first-year MBA student at Wharton double-majoring in Health Care Management and Entrepreneurship.  He graduated with an MD from the University of London, and attained an MS with distinction in Interprofessional Studies.  Terence completed his residency in Psychiatry in London in 1992, during which time he was actively involved in hospital management.  At Wharton, Terence is an Assistant Producer of Follies and Co-Leader of the Healthcare International Volunteer Project.  After the MBA, Terence would like a position with a strategic consulting firm, or in strategic planning for a pharmaceutical or biotechnology company.